These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9148026)

  • 1. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins.
    Battista S; Bar F; Mengozzi G; Zanon E; Grosso M; Molino G
    J Hepatol; 1997 Jan; 26(1):75-80. PubMed ID: 9148026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].
    Kim MY; Baik SK
    Korean J Gastroenterol; 2009 Sep; 54(3):143-8. PubMed ID: 19844149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
    Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
    World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis.
    Sugimoto H; Kaneko T; Hirota M; Tezel E; Nakao A
    J Hepatol; 2002 Nov; 37(5):578-83. PubMed ID: 12399222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites.
    Martinet JP; Legault L; Cernacek P; Roy L; Dufresne MP; Spahr L; Fenyves D; Pomier-Layrargues G
    J Hepatol; 1996 Nov; 25(5):700-6. PubMed ID: 8938548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in prostaglandin and nitric oxide levels in the hyperdynamic circulation following liver resection.
    Lai OF; Chow PK; Tan S; Song IC; Soo KC; Aw SE; Yu WK; Fook-Chong SM; Satchithanantham S; Chan ST
    J Gastroenterol Hepatol; 2000 Aug; 15(8):895-901. PubMed ID: 11022830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt.
    Trebicka J; Krag A; Gansweid S; Appenrodt B; Schiedermaier P; Sauerbruch T; Spengler U
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1218-25. PubMed ID: 21971377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrate kinetics in patients with compensated cirrhosis: correlation with hemodynamics.
    Shijo H; Yokoyama M; Ota K; Kokawa H; Kubara K; Kim T; Akiyoshi N; Okumura M; Inoue K
    Am J Gastroenterol; 1996 Oct; 91(10):2190-4. PubMed ID: 8855746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts on the role of nitric oxide in portal hypertension.
    Hu LS; George J; Wang JH
    World J Gastroenterol; 2013 Mar; 19(11):1707-17. PubMed ID: 23555159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
    Afzelius P; Bazeghi N; Bie P; Bendtsen F; Vestbo J; Møller S
    Liver Int; 2011 Oct; 31(9):1381-7. PubMed ID: 21745317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase activity in the splanchnic vasculature of patients with cirrhosis: relationship with hemodynamic disturbances.
    Albornoz L; Motta A; Alvarez D; Estevez A; Bandi JC; McCormack L; Matera J; Bonofiglio C; Ciardullo M; De Santibañes E; Gimeno M; Gadan A
    J Hepatol; 2001 Oct; 35(4):452-6. PubMed ID: 11682028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intrahepatic portal-systemic shunting on hepatic ammonia extraction in patients with cirrhosis.
    Nomura F; Ohnishi K; Terabayashi H; Nakai T; Isobe K; Takekoshi K; Okuda K
    Hepatology; 1994 Dec; 20(6):1478-81. PubMed ID: 7982647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
    Nielsen MJ; Lehmann J; Leeming DJ; Schierwagen R; Klein S; Jansen C; Strassburg CP; Bendtsen F; Møller S; Sauerbruch T; Karsdal MA; Krag A; Trebicka J
    Dig Dis Sci; 2015 Nov; 60(11):3456-64. PubMed ID: 26138655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide and portal hypertension.
    González-Abraldes J; García-Pagán JC; Bosch J
    Metab Brain Dis; 2002 Dec; 17(4):311-24. PubMed ID: 12602508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
    Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
    Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory regulation of splanchnic and systemic venous return in normal subjects and in patients with hepatic cirrhosis.
    Moreno AH; Burchell AR
    Surg Gynecol Obstet; 1982 Feb; 154(2):257-67. PubMed ID: 7058489
    [No Abstract]   [Full Text] [Related]  

  • 19. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.
    Zafra C; Abraldes JG; Turnes J; Berzigotti A; Fernández M; Garca-Pagán JC; Rodés J; Bosch J
    Gastroenterology; 2004 Mar; 126(3):749-55. PubMed ID: 14988829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl(4)-induced cirrhosis.
    Bhimani EK; Serracino-Inglott F; Sarela AI; Batten JJ; Mathie RT
    J Surg Res; 2003 Jul; 113(1):172-8. PubMed ID: 12943827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.